159 related articles for article (PubMed ID: 12819106)
1. Pseudomonas aeruginosa ExoU, a toxin transported by the type III secretion system, kills Saccharomyces cerevisiae.
Rabin SD; Hauser AR
Infect Immun; 2003 Jul; 71(7):4144-50. PubMed ID: 12819106
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU.
Sato H; Frank DW; Hillard CJ; Feix JB; Pankhaniya RR; Moriyama K; Finck-Barbançon V; Buchaklian A; Lei M; Long RM; Wiener-Kronish J; Sawa T
EMBO J; 2003 Jun; 22(12):2959-69. PubMed ID: 12805211
[TBL] [Abstract][Full Text] [Related]
3. Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU.
Rabin SD; Hauser AR
Infect Immun; 2005 Jan; 73(1):573-82. PubMed ID: 15618197
[TBL] [Abstract][Full Text] [Related]
4. In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors.
Phillips RM; Six DA; Dennis EA; Ghosh P
J Biol Chem; 2003 Oct; 278(42):41326-32. PubMed ID: 12915403
[TBL] [Abstract][Full Text] [Related]
5. A C-terminal domain targets the Pseudomonas aeruginosa cytotoxin ExoU to the plasma membrane of host cells.
Rabin SD; Veesenmeyer JL; Bieging KT; Hauser AR
Infect Immun; 2006 May; 74(5):2552-61. PubMed ID: 16622190
[TBL] [Abstract][Full Text] [Related]
6. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia.
Schulert GS; Feltman H; Rabin SD; Martin CG; Battle SE; Rello J; Hauser AR
J Infect Dis; 2003 Dec; 188(11):1695-706. PubMed ID: 14639541
[TBL] [Abstract][Full Text] [Related]
7. Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia.
Howell HA; Logan LK; Hauser AR
mBio; 2013 Mar; 4(2):e00032-13. PubMed ID: 23481600
[TBL] [Abstract][Full Text] [Related]
8. Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity.
Veesenmeyer JL; Howell H; Halavaty AS; Ahrens S; Anderson WF; Hauser AR
Infect Immun; 2010 Aug; 78(8):3346-57. PubMed ID: 20479080
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoU.
Tyson GH; Hauser AR
Infect Immun; 2013 Aug; 81(8):2873-81. PubMed ID: 23716613
[TBL] [Abstract][Full Text] [Related]
10. Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis.
Miyata S; Casey M; Frank DW; Ausubel FM; Drenkard E
Infect Immun; 2003 May; 71(5):2404-13. PubMed ID: 12704110
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.
Allewelt M; Coleman FT; Grout M; Priebe GP; Pier GB
Infect Immun; 2000 Jul; 68(7):3998-4004. PubMed ID: 10858214
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU.
Pankhaniya RR; Tamura M; Allmond LR; Moriyama K; Ajayi T; Wiener-Kronish JP; Sawa T
Crit Care Med; 2004 Nov; 32(11):2293-9. PubMed ID: 15640644
[TBL] [Abstract][Full Text] [Related]
13. Interactions of the effector ExoU from
Springer TI; Reid TE; Gies SL; Feix JB
J Biol Chem; 2019 Dec; 294(50):19012-19021. PubMed ID: 31662432
[No Abstract] [Full Text] [Related]
14. Pseudomonas aeruginosa cytotoxin ExoU is injected into phagocytic cells during acute pneumonia.
Diaz MH; Hauser AR
Infect Immun; 2010 Apr; 78(4):1447-56. PubMed ID: 20100855
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa.
Gendrin C; Contreras-Martel C; Bouillot S; Elsen S; Lemaire D; Skoufias DA; Huber P; Attree I; Dessen A
PLoS Pathog; 2012; 8(4):e1002637. PubMed ID: 22496657
[TBL] [Abstract][Full Text] [Related]
16. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
Finck-Barbançon V; Goranson J; Zhu L; Sawa T; Wiener-Kronish JP; Fleiszig SM; Wu C; Mende-Mueller L; Frank DW
Mol Microbiol; 1997 Aug; 25(3):547-57. PubMed ID: 9302017
[TBL] [Abstract][Full Text] [Related]
17. Identification of superoxide dismutase as a cofactor for the pseudomonas type III toxin, ExoU.
Sato H; Feix JB; Frank DW
Biochemistry; 2006 Aug; 45(34):10368-75. PubMed ID: 16922513
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol 4,5-Bisphosphate-Dependent Oligomerization of the Pseudomonas aeruginosa Cytotoxin ExoU.
Zhang A; Veesenmeyer JL; Hauser AR
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 28993456
[TBL] [Abstract][Full Text] [Related]
19. Eukaryotic localization, activation and ubiquitinylation of a bacterial type III secreted toxin.
Stirling FR; Cuzick A; Kelly SM; Oxley D; Evans TJ
Cell Microbiol; 2006 Aug; 8(8):1294-309. PubMed ID: 16882033
[TBL] [Abstract][Full Text] [Related]
20. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
Lee VT; Smith RS; Tümmler B; Lory S
Infect Immun; 2005 Mar; 73(3):1695-705. PubMed ID: 15731070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]